Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
ETEC strain B7A (O148:H28 CS6+ LT+ST+) (Lot 0481) in Buffer
United Therapeutics Europe Ltd
Healthy Volunteer
1 trial -
Intranasal Oxytocin (OT) 24 IU
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Participants
1 trial -
Losartan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
MDA
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Modafinil Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Naltrexone and 2-butanol
BRIGHT MINDS BIOSCIENCES INC.
Healthy Adults
1 trial -
Nutritional Supplement
Aspire Biopharma Holdings
Healthy
1 trial -
Oral Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
2 trials -
Phenytoin single dose (300 mg)
United Therapeutics Europe Ltd
Healthy
1 trial -
Placebo
KYOWA KIRIN AUSTRALIA PTY LTD
Healthy
1 trial -
Placebo
United Therapeutics Europe Ltd
Healthy
1 trial -
Polyphenol-rich extract
Atrium Therapeutics
Healthy Elderly
1 trial -
Propranolol
Eli Lilly and Company
Healthy
1 trial -
Ramelteon
Takeda
Healthy
1 trial -
Whole exome sequencing
United Therapeutics Europe Ltd
Healthy Adults
1 trial -
Wild blueberry containing foods
United Therapeutics Europe Ltd
Healthy
1 trial -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
7 trials -
oxytocin treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
placebo (compared to vasoconstrictor)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Adult Male
1 trial -
vasoconstrictor and oxytocin treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.